Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

HS TECH June 2026 Rebalance: Pre-Implementation Update

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

<ul>
<li>Hang Seng announced index review for the June 2026 Rebalance. Our pre-announcement note dated 11 May 2026 called both ADD candidates and both DELETE candidates correctly.</li>
<li>We analyzed dynamics around two ADDs, from a historical perspective, on the post-announcement positioning.</li>
<li>We also analyzed dynamics around two DELETEs. Both DELETEs fell by similar magnitudes with slightly above-baseline volume</li>
</ul>


Hang Seng announced index review for the June 2026 Rebalance. Our pre-announcement note dated 11 May 2026 called both ADD candidates and both DELETE candidates correctly.
We analyzed dynamics around two ADDs, from a historical perspective, on the post-announcement positioning.
We also analyzed dynamics around two DELETEs. Both DELETEs fell by similar magnitudes with slightly above-baseline volume


Kingdee International Software Group (268 HK)

HS TECH June 2026 Rebalance: Post-Announcement Positioning

MiniMax

HS TECH June 2026 Rebalance: Post-Announcement Positioning